The major anti-tumor immune response occurs by activation of CD8+ cytotoxic T lymphocytes (CTLs) whereas CD4+ T cells help in maintaining CTL numbers and support CTLs to gain entry into tumors (86). Here, CD4 is linked to neoplasm.